By

Ilaria Bonifazi

Rinnovata la partnership tra VisMederi e Emma Villas Siena

09 Sep 2016
0
Per il terzo anno consecutivo si rinnova la partnership tra VisMederi e Emma Villas Siena, la squadra di volley maschile che milita in serie A2. Due realtà di successo del territorio senese che vedono proseguire la loro collaborazione anche per la prossima stagione sportiva, la...
Leggi/Read →

VisMederi: the new corporate structure presented

07 Sep 2016
0
VisMederi Srl, the Tuscan Company operating in the field of Life Sciences and Public Health, has announced its new corporate structure today. The agreement on reorganization completed in recent days involved the sale to Prof. Emanuele Montomoli of the 66.66% shares previously...
Leggi/Read →

VisMederi, new collaboration with Eurocine Vaccines

11 Aug 2016
0
Vid sidan av mat och dryck har italienska Toscana gjort sig känd som en av Europas tätaste Bioregioner. Med sina tre universitet – Florens, Pisa och Siena – och forskning i världsklass är det ett av de mest framstående klustren inom Life Science. Många läkemedelsbolag har därför...
Leggi/Read →

VisMederi at the international Vaccine Summit in London

13 Oct 2015
0
VisMederi joins an international meeting, the 2015 Vaccine Summit in the UK, that will be held in London from today to 15th October. For the third year, this international interdisciplinary event is an open forum for discussion of all scientific and clinical aspects of vaccine...
Leggi/Read →

VisMederi at the international conference IVW 2015 “Influenza vaccines for the world”

05 Oct 2015
0
Simona Piccirella and Emanuele Montomoli, respectively Scientific director and Chief operating officer of VisMederi, will speak at the international conference that will be held in Albufeira , Portugal, from 6 to 9 October. Influenza Vaccines for the World – IVW 2015 is the fifth...
Leggi/Read →

Discovered mechanism connecting influenza and narcolepsy, Montomoli in the research team

02 Jul 2015
0
An international research team coordinated by the Research Center of Novartis Vaccines and Diagnostics srl (company of GSK Group), has discovered the mechanism that develop narcolepsy after an influenza or an influenza vaccination in subjects genetically predisposed. The study...
Leggi/Read →

VisMederi alla BIO Convention 2015 di Filadelfia

15 Jun 2015
0
C’è anche VisMederi tra le imprese italiane in vetrina dal 15 al 17 giugno alla BIO International Convention di Filadelfia, il più importante evento mondiale del biopharma. L’appuntamento, che riunisce i top decision-maker del settore, si terrà in Pennsylvania, stato degli...
Leggi/Read →

Se i ricercatori italiani fanno gola al Giappone

21 May 2015
0
Leggi/Read →

VisMederi is financially healthy – 2014 turnover reaches 1.6 million Euro

06 May 2015
0
VisMederi has obtained positive results in 2014, proving to be internationally competitive in the offer of qualified services in the field of Life Sciences. The Company, founded in Siena in 2009 by Chiara Gentile, Emanuele Montomoli and Simona Piccirella, closed the financial...
Leggi/Read →

VisMederi è in salute, 2014 chiuso con un fatturato di 1,6 milioni di euro

06 May 2015
0
Leggi/Read →
12

Work with us

Find out about opening job positions at VisMederi. You can send your CV along with a Handling of Personal Information Statement of Consent at the following e-mail address: HR@vismederi.com

Privacy

Privacy Policy

Cookie Policy

Whistleblowing

TAMPONI COVID-19

drive through

PRENOTAZIONI
dalle 09:00 alle 12:30
tel. 347 0334843
prenotazione.tamponi@vismederi.com

PRESTAZIONI DIAGNOSTICHE

CONTATTI

diagnostic@vismederi.com
tel. 347 033 4843

Contact

info@vismederi.com
vismederi@pec.it

Laboratories

VisMederi srl
Strada del Petriccio e Belriguardo, 35
53100 Siena, Italia

phone +39 0577 381254 / 55
fax: +39 0577 381258

Headquarter

Via Franco Ferrini 53
Loc. Tognazza – San Martino
53035 Monteriggioni – Siena, Italy

phone +39 0577 1520990

VisMederi srl - P. Iva 01269140529 - All rights reserved ® 2014 - Credits